About Robbie Loewith
Robbie Loewith received his bachelor in Biochemistry and Molecular Biology/Genetics in 1994 from the University of Guelph (Ontario, Canada). His PhD thesis – describing a novel tumor suppressor – was conducted at the Cancer Institute of Southern Alberta, in Dallan Young ‘s lab. He was granted his PhD degree in 2000 from the University of Calgary (Alberta, Canada). In 2005, following post-doctoral studies on the control of cell growth and in the laboratory of Michael Hall at the Biozentrum, University of Basle, Robbie Loewith joined the department of Molecular Biology of the University of Geneva as a project leader. In 2006, he was awarded an SNSF professorship, in 2008 an ERC Starting grant and in 2014 an ERC Consolidator grant. Today, Robbie Loewith is Full Professor in the Department of Molecular Biology.
Robbie Loewith has been part of the NCCR Chemical Biology as a project leader since 2010. Since December 2021, Robbie is Director of the NCCR Chemical Biology. He is also the Head of the educational committee for the Master’s in Chemical Biology and a member of the NCCR steering committee.
With particular focus on the Target Of Rapamycin kinases, his group uses chemical genetic approaches in yeast to dissect complex signalling pathways conserved in all eukaryotes.
Read more about Robbie Loewith’s research on his lab website.
Contact
University of Geneva
Department of Molecular Biology
30, quai Ernest-Ansermet
CH-1211, Geneva 4, Switzerland
Phone: +41 (0)22 37 96116
Email: [email protected]
